Wikidata

(Q113889435)

English

Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
A Phase III Study to Compare HS627 vs. Pertuzumab on the Efficacy, Safety and Immunogenicity in Combination With Trastuzumab and Docetaxel as Neoadjuvant Therapy in Patients With Early-stage or Locally Advanced HER2 Positive Breast Cancer (English)
0 references
start time
30 June 2020
0 references
end time
20 November 2021
0 references
number of participants
408
0 references
research intervention
tubulin modulators
0 references
mitotic inhibitor
0 references
mitosis modulators
0 references
mechanism of action
0 references
docetaxel
0 references
trastuzumab
0 references
pertuzumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113889435&oldid=2149438844"